184150-81-0 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Ethyl-1H-indole-6-carboxylic acid Methyl ester is used as a building block or intermediate in the production of various drugs. Its unique structure and functional groups allow for the synthesis of a wide range of pharmaceutical compounds with potential therapeutic applications.
Used in Anti-inflammatory Applications:
2-Ethyl-1H-indole-6-carboxylic acid Methyl ester has been studied for its potential anti-inflammatory properties. It may be used as an active pharmaceutical ingredient or a precursor in the development of anti-inflammatory drugs, helping to alleviate inflammation and related symptoms.
Used in Antioxidant Applications:
2-Ethyl-1H-indole-6-carboxylic acid Methyl ester has also been investigated for its antioxidant properties, which may have therapeutic implications. 2-Ethyl-1H-indole-6-carboxylic acid Methyl ester can be used as an antioxidant agent in pharmaceutical formulations, protecting cells from oxidative stress and reducing the risk of various diseases associated with oxidative damage.
Used in Chemical Research:
Due to its unique structure and properties, 2-Ethyl-1H-indole-6-carboxylic acid Methyl ester is also used in chemical research for the development of new synthetic methods, understanding its reactivity, and exploring its potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 184150-81-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,4,1,5 and 0 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 184150-81:
(8*1)+(7*8)+(6*4)+(5*1)+(4*5)+(3*0)+(2*8)+(1*1)=130
130 % 10 = 0
So 184150-81-0 is a valid CAS Registry Number.
184150-81-0Relevant academic research and scientific papers
Method of inhibiting neoplastic cells with indole derivatives
-
, (2008/06/13)
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to indole derivatives.
Method for inhibiting neoplastic cells with indole derivatives
-
, (2008/06/13)
A method for inhibiting neoplastic cells and related conditions by exposing them to substituted indole derivatives.
Indole derivatives as cGMP-PDE inhibitors
-
, (2008/06/13)
Compounds of the formula (I): STR1 and their pharmaceutically acceptable compositions are useful in inhibiting the activity of cyclic guanosine 3',5'-monophosphate phosphodiesterase.
